Výsledky vyhledávání - "Maria E Amutio"

Effectiveness and Tolerance of Azacitidine for Treating Patients with Chronic Myelomonocytic Leukemia in Community-Based Management

Autor: Marta Laguna García, Angela Ibañez, Maria E Amutio, Guillermo Sanz, Regina Garcia, Jose F Falantes, Alicia Bailen, Manuel Almagro, Reyes Sancho-Tello

Publikováno v: Blood. 114:4855-4855

Abstract 4855 Introduction Azacitidine (AZA) was recently approved in Europe by the EMEA for the treatment of Chronic Myelomonocytic Leukemia (CMMoL). Traditionally, CMMoL has been considered as part of the myelodysplastic syndrome (MDS) according to

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::461b894c1d7638e817c165b75fb94165
https://doi.org/10.1182/blood.v114.22.4855.4855

Zobrazit plný text záznamu

Azacitidine Is Effective in Patients with Low Intermediate-1 Risk Myelodysplastic Syndrome Managed in Community Based Practice: Preliminary Data From the Spanish Compassionate Use Registry

Autor: Maria-Teresa Bernal, Raquel de Paz, Antonio Figueredo, Regina Garcia, Guillermo Sanz, Dunia de Miguel, Mar Tormo, Jose L. Guzman, Maria E Amutio

Publikováno v: Publons

Abstract 3801 Poster Board III-737 Background Myelodysplastic syndrome (MDS) is comprised of a group of heterogeneous hematological disorders. Although the decision regarding treatment of a patient with MDS is based on performance status, age, patien

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::041c5288d1cb9ff714ab0ba0f15bc2ae
https://publons.com/publon/5621079/

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání